Events

CBE, CNSI, CSEP, GSDS, AND WISE PRESENT A CAREER TALK SEMINAR: JOE KIANI: Founder, Chairman, and CEO Masimo Corporation

Thursday, April 7, 2016 Elings Hall 1601 2:00– 3:00 pm

CBE CO Sponsored Seminar presents

Bioengineering Career Talk

Thursday, April 7, 2016

Elings Hall 1601

2:00– 3:00 pm

*Light refreshments will be provided*

 RSVP at: https://csep.cnsi.ucsb.edu/forms/PDS/Registration.php

Joe Kiani

Founder, Chairman, and CEO

Masimo Corporation

Patient Safety and Innovation in Healthcare

BIO: Joe Kiani runs one of the world’s most admired medical technology companies, is an inventor of worldchanging

noninvasive patient monitoring devices, a trusted voice for patient safety and care, and a conventionbreaking

maverick. As the founder, Chairman, and CEO of Masimo Corporation, a global medical technology

innovator, Mr. Kiani has been a beacon for patient safety and innovation in healthcare for more than 20 years.

 

Abstract:

Convinced that the use of adaptive signal processing could solve the problems of motion artifact and signal

noise that plagued pulse oximetry, Joe Kiani founded Masimo in 1989 to improve the reliability of noninvasive

patient monitoring. Under his leadership, Masimo has grown from a “garage start up” into a successful

publicly traded company (NASDAQ: MASI) employing more than 3,000 people worldwide and providing its

market-leading Masimo SET® Measure-through Motion and Low Perfusion pulse oximetry technology to

leading OEM patient monitoring manufacturers. Today, Masimo is an innovative powerhouse delivering key

noninvasive medical breakthroughs, including: rainbow Pulse CO-Oximetry™—the first blood constituent

monitoring platform to measure multiple blood constituents noninvasively that previously could only be

measured invasively and help clinicians reduce risky blood transfusions; Patient SafetyNet™—the first

remote monitoring and wireless clinician notification system shown to help hospitals improve patient safety

and clinical outcomes by dramatically decreasing rescue events and costly ICU transfers; rainbow Acoustic

MonitoringTM—the first noninvasive and continuous acoustic respiration rate (RRaTM) monitoring

technology; and Root, the new clinical information platform, that is expected to reduce clinical distraction, complexity and cost, and accelerate innovation in patient monitoring and care.